Pfizer Inc. (PFE): ev to ebit, 10 filed years
EV/EBIT at Pfizer Inc. was 20.46x in FY2025, the newest filed year. Across the 7 computed years from FY2019 it ranged from 9.24x (FY2022) to 72.41x (FY2023), with a median of 20.40x.
Tonight's figure on the company page: 23.01x, at the close of 2026-10-15, recomputed 2026-10-15. The table is each filed year on its own terms, with the formula below; the current figure may use trailing twelve months or, where the explainer says so, a different denominator.
Year by year
| Fiscal year | EV/EBIT | Read from |
|---|---|---|
| FY2016 The filed borrowings do not add up to a total we can stand behind: the filer's own liability subtotals leave room for debt we did not read. | n/a | 10-K, filed 2017-02-23 |
| FY2017 The filed borrowings do not add up to a total we can stand behind: the filer's own liability subtotals leave room for debt we did not read. | n/a | 10-K, filed 2018-02-22 |
| FY2018 The filed borrowings do not add up to a total we can stand behind: the filer's own liability subtotals leave room for debt we did not read. | n/a | 10-K, filed 2019-02-28 |
| FY2019 | 20.40x | 10-K, filed 2020-02-27 |
| FY2020 | 29.09x | 10-K, filed 2021-02-25 |
| FY2021 | 14.71x | 10-K, filed 2022-02-24 |
| FY2022 | 9.24x | 10-K, filed 2023-02-23 |
| FY2023 | 72.41x | 10-K, filed 2024-02-22 |
| FY2024 | 19.54x | 10-K, filed 2025-02-27 |
| FY2025 | 20.46x | 10-K, filed 2026-02-26 |
How each year is computed
(Close at fiscal year end x diluted shares + total debt - cash) / operating income
P/E, free cash flow yield and EV to EBIT set each filed year against the close on or within a week before that fiscal year's end. The price archive here is about five years deep, so older years of those three read n/a. Per-share figures and share counts are put on today's share count after a confirmed split, the basis the price archive is kept on.
Read further
A computation on accounts filed with the SEC, not a recommendation and not advice. Past filings do not indicate future results. Risk disclaimer.